Earl Douglas - SVP, General Counsel at Allogene Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
SVP, General Counsel
Stock Symbol
ALLO on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Earl Douglas since 12/22/2023

Holdings reported by Earl Douglas for Allogene Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 449K $1.25M $2.79 Aug 21, 2024 Direct
Stock Option (Right to buy) 148K Jan 25, 2024 Direct Common Stock

Transactions reported by Earl Douglas for Allogene Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.